Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;99(3):494-496.
doi: 10.1002/ajh.27205. Epub 2024 Jan 19.

T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments

Victoria A Vardell  1 , Daniel A Ermann  1 , Lindsey Fitzgerald  1 , Harsh Shah  1 , Boyu Hu  1 , Deborah M Stephens  1   2
Affiliations
Free article

T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments

Victoria A Vardell et al. Am J Hematol. 2024 Mar.
Free article

Abstract

Survival remains poor for T-cell prolymphocytic leukemia, though treatment in recent years, associated with access to novel therapies, and management at academic medical centers is associated with improved outcomes. There remains a critical need to improve the available treatment options for this population, and access to specialized academic medical centers, comprehensive supportive care, clinical trials, and early palliative care remains essential for T-PLL patients.

PubMed Disclaimer

References

REFERENCES

    1. Swerdlow SH, Campo E, Harris NL, et al., eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. IARC Press; 2017.
    1. Staber PB, Herling M, Bellido M, et al. Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 2019;134(14):1132-1143.
    1. Chandran R, Gardiner SK, Fenske TS, Spurgeon ES. Survival trends in T cell prolymphocytic leukemia: a SEER database analysis. Leuk Lymphoma. 2016;57(4):942-944.
    1. Jain P, Aoki E, Keating M, et al. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). Ann Oncol. 2017;28(7):1554-1559.
    1. Braun T, Jan J, Wahnschaffe L, Herling M. Advances and perspectives in the treatment of T-PLL. Curr Hematol Malig Rep. 2020;15:113-124.

Publication types

MeSH terms

LinkOut - more resources